Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: An effect counteracted by GLP-1 through the cyclic AMP/PKA pathway

Cell and Tissue Research

Volumn 319, Issue 2, 2005, Pages 221-230

  Jimenez Feltstrom, Javier ^a   Lundquist, Ingmar ^a   Salehi, Albert ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

cNOS; Glucose toxicity; iNOS; Insulin secretion; Pancreatic islets; Rat (male, Sprague Dawley)

Indexed keywords

BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SCAVENGER;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERGLYCEMIA; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BUCLADESINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC N-OXIDES; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; IMIDAZOLES; INSULIN; ISLETS OF LANGERHANS; ISOQUINOLINES; MALE; MICRODISSECTION; MICROSCOPY, CONFOCAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDE FRAGMENTS; PROTEIN KINASE INHIBITORS; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES;

EID: 12944303107     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-004-1013-4     Document Type: Article

References (44)

1. Akesson B, Henningsson R, Salehi A, Lundquist I (1999) Islet constitutive nitric oxide synthase and glucose regulation of insulin release in mice. J Endocrinol 163:39-48
2. Alm P, Ekstrom P, Henningsson R, Lundquist I (1999) Morphological evidence for the existence of nitric oxide and carbon monoxide pathways in the rat islets of Langerhans: an immunocytochemical and confocal microscopical study. Diabetologia 42:978-986
3. Belin VD, Mabley JG, James RF, Swift SM, Clayton HA, Titheradge MA, Green IC (1999) Glucagon decreases cytokine induction of nitric oxide synthase and action on insulin secretion in RIN5F cells and rat and human islets of Langerhans. Cytokine 11:585-592
4. Beshay E, Prud'homme GJ (2001) Inhibitors of phosphodiesterase isoforms III or IV suppress islet-cell nitric oxide production. Lab Invest 81:1109-1117
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
6. Ceriello A, Quagliaro L, D'Amico M, DiFilippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D (2002) Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51:1076-1082
7. Christopherson KS, Bredt DS (1997) Nitric oxide in excitable tissues: physiological roles and disease. J Clin Invest 100:2424-2429
8. Corbett JA, McDaniel ML (1992) Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes 41:897-903
9. Drucker DJ (2003) Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology 144:5145-5148
10. Dunger A, Cunningham JM, Delaney CA, Lowe JE, Green MH, Bone AJ, Green IC (1996) Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement. Diabetes 45:183-189
11. Eizirik DL, Korbutt GS, Hellerstrom C (1992) Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J Clin Invest 90:1263-1268
12. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N (1996) The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39:875-890
13. Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52:1-8
14. Flodstrom M, Tyrberg B, Eizirik DL, Sandler S (1999) Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes 48:706-713
15. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP (1985) An improved method for isolation of mouse pancreatic islets. Transplantation 40:437-438
16. Gross R, Roye M, Manteghetti M, Broca C, Hillaire-Buys D, Masiello P, Ribes G (1997) Mechanisms involved in the effect of nitric oxide synthase inhibition on L-arginine-induced insulin secretion. Br J Pharmacol 120:495-501
17. Guo L, Zhang Z, Green K, Stanton RC (2002) Suppression of interleukin-1 beta-induced nitric oxide production in RINm5F cells by inhibition of glucose-6-phosphate dehydrogenase. Biochemistry 41:14726-14733
18. Hadjivassiliou V, Green MH, James RF, Swift SM, Clayton HA, Green IC (1998) Insulin secretion, DNA damage, and apoptosis in human and rat islets of Langerhans following exposure to nitric oxide, peroxynitrite, and cytokines. Nitric Oxide 2:429-441
19. Harbrecht BG, Wirant EM, Kim YM, Billiar TR (1996) Glucagon inhibits hepatocyte nitric oxide synthesis. Arch Surg 131:1266-1272
20. Henningsson R, Lundquist I (1998) Arginine-induced insulin release is decreased and glucagon increased in parallel with islet NO production. Am J Physiol 275:E500-E506
21. Henningsson R, Alm P, Lindstrom E, Lundquist I (2000) Chronic blockade of NO synthase paradoxically increases islet NO production and modulates islet hormone release. Am J Physiol Endocrinol Metab 279:E95-E107
22. Henningsson R, Aim P, Lundquist I (2001) Evaluation of islet heme oxygenase-CO and nitric oxide synthase-NO pathways during acute endotoxemia. Am J Physiol Cell Physiol 280:C1242-C1254
23. Henningsson R, Salehi A, Lundquist I (2002) Role of nitric oxide synthase isoforms in glucose-stimulated insulin release. Am J Physiol Cell Physiol 283:C296-C304
24. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH (2001) Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 3:193-197
25. Knowles RG, Moncada S (1994) Nitric oxide synthases in mammals. Biochem J 298:249-258
26. Lajoix AD, Reggio H, Chardes T, Peraldi-Roux S, Tribillac F, Roye M, Dietz S, Broca C, Manteghetti M, Ribes G, Wollheim CB, Gross R (2001) A neuronal isoform of nitric oxide synthase expressed in pancreatic beta-cells controls insulin secretion. Diabetes 50:1311-1323
27. Lakey JR, Suarez-Pinzon WL, Strynadka K, Korbutt GS, Rajotte RV, Mabley JG, Szabo C, Rabinovitch A (2001) Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet beta cells. Lab Invest 81:1683-1692
28. Mandrup-Poulsen T (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029
29. Marshak S, Leibowitz G, Bertuzzi F, Socci C, Kaiser N, Gross DJ, Cerasi E, Melloul D (1999) Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 48:1230-1236
30. Panagiotidis G, Alm P, Lundquist I (1992) Inhibition of islet nitric oxide synthase increases arginine-induced insulin release. Eur J Pharmacol 229:277-278
31. Panagiotidis G, Akesson B, Rydell EL, Lundquist I (1995) Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues. Br J Pharmacol 114:289-296
32. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 67:1185-1248
33. Renstrom E, Eliasson L, Rorsman P (1997) Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells. J Physiol (Lond) 502:105-118
34. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H (2003) Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52:581-587
35. Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care 13:610-630
36. Salehi A, Carlberg M, Henningson R, Lundquist I (1996) Islet constitutive nitric oxide synthase: biochemical determination and regulatory function. Am J Physiol 270:C1634-C1641
37. Salehi A, Parandeh F, Lundquist I (1998) Signal transduction in islet hormone release: interaction of nitric oxide with basal and nutrient-induced hormone responses. Cell Signal 10:645-651
38. Salehi A, Ekelund M, Henningsson R, Lundquist I (2001) Total parenteral nutrition modulates hormone release by stimulating expression and activity of inducible nitric oxide synthase in rat pancreatic islets. Endocrine 16:97-104
39. Salehi A, Ekelund M, Lundquist I (2003) Total parenteral nutrition-stimulated activity of inducible nitric oxide synthase in rat pancreatic islets is suppressed by glucagon-like peptide-1. Horm Metab Res 35:48-54
40. Schmidt HH, Warner TD, Ishii K, Sheng H, Murad F (1992) Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science 255:721-723
41. Smukler SR, Tang L, Wheeler MB, Salapatek AM (2002) Exogenous nitric oxide and endogenous glucose-stimulated beta-cell nitric oxide augment insulin release. Diabetes 51:3450-3460
42. Takamura T, Kato I, Kimura N, Nakazawa T, Yonekura H, Takasawa S, Okamoto H (1998) Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis. J Biol Chem 273:2493-2496
43. 2+, cAMP and diacylglycerol. Mol Cell Endocrinol 70:119-137
44. Zawalich WS, Tesz GJ, Zawalich KC (2002) Inhibitors of phosphatidylinositol 3-kinase amplify insulin release from islets of lean but not obese mice. J Endocrinol 174:247-258